EIF2AK3 and Alzheimer disease: In the context of Alzheimer’s disease models, further indirect mechanisms may be involved following UPR activation—for example, via PERK activation of glycogen synthase kinase 3β, and subsequent increased tau phosphorylation and beta amyloid precursor cleaving protein (BACE) expression, increasing amyloidogenesis [44].